Background and aims: Liver is the major organ involved in apoA-I synthesis and HDL-C turnover, but the impact of apoA-I/HDL on hepatic transcriptome has never been investigated before. In the present study, a transcriptomic analysis by high-throughput RNA-seq was conducted in the liver of atherosclerosis-prone mice, with the aim of identifying new genes/pathways modulated by apoA-I/HDL with a potential effect on atherosclerosis development. Methods and results: Eight-week-old apoE knockout (apoEKO) mice lacking apoA-I/HDL (DKO) and with physiological levels of apoA-I/HDL (DKO/hA-I) were fed either a standard rodent diet (SRD) or a Western diet (WD) for 22 weeks. After both dietary treatments, DKO mice were characterized by lower cholesterol levels, but increased atherosclerosis development, compared to DKO/hA-I mice. The liver transcriptome of DKO and DKO/hA-I mice fed SRD diverged in a relatively small number of genes, suggestive of a greater activation of the PPAR signaling pathway and the retinoid metabolism pathway in DKO/hA-I mice. Following WD, transcriptomic analysis highlighted in both genotypes an upregulated expression of immune/inflammatory genes and a reduced activation of the retinoid metabolism. The evaluation of the hepatic response of the two genotypes to the dietary switch from SRD to WD revealed strong divergences in genes involved in metabolic pathways only in the presence of apoA-I/HDL, with reduced endogenous sterol biosynthesis and glutathione metabolism, together with increased glucose metabolism. Conclusion: The presence or absence of apoA-I expression differently alters hepatic pathways involved not only in cholesterol metabolism, but also in those of glutathione and glucose metabolism.

The lack of apoA-I in apoE-KO mice affects the liver transcriptome / E. Franchi, A. Colombo, S. Manzini, M. Busnelli, G. Chiesa. - In: NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. - ISSN 0939-4753. - 35:8(2025 Aug), pp. 103920.1-103920.12. [10.1016/j.numecd.2025.103920]

The lack of apoA-I in apoE-KO mice affects the liver transcriptome

E. Franchi
Primo
;
S. Manzini;M. Busnelli
;
G. Chiesa
Ultimo
2025

Abstract

Background and aims: Liver is the major organ involved in apoA-I synthesis and HDL-C turnover, but the impact of apoA-I/HDL on hepatic transcriptome has never been investigated before. In the present study, a transcriptomic analysis by high-throughput RNA-seq was conducted in the liver of atherosclerosis-prone mice, with the aim of identifying new genes/pathways modulated by apoA-I/HDL with a potential effect on atherosclerosis development. Methods and results: Eight-week-old apoE knockout (apoEKO) mice lacking apoA-I/HDL (DKO) and with physiological levels of apoA-I/HDL (DKO/hA-I) were fed either a standard rodent diet (SRD) or a Western diet (WD) for 22 weeks. After both dietary treatments, DKO mice were characterized by lower cholesterol levels, but increased atherosclerosis development, compared to DKO/hA-I mice. The liver transcriptome of DKO and DKO/hA-I mice fed SRD diverged in a relatively small number of genes, suggestive of a greater activation of the PPAR signaling pathway and the retinoid metabolism pathway in DKO/hA-I mice. Following WD, transcriptomic analysis highlighted in both genotypes an upregulated expression of immune/inflammatory genes and a reduced activation of the retinoid metabolism. The evaluation of the hepatic response of the two genotypes to the dietary switch from SRD to WD revealed strong divergences in genes involved in metabolic pathways only in the presence of apoA-I/HDL, with reduced endogenous sterol biosynthesis and glutathione metabolism, together with increased glucose metabolism. Conclusion: The presence or absence of apoA-I expression differently alters hepatic pathways involved not only in cholesterol metabolism, but also in those of glutathione and glucose metabolism.
No
English
Apolipoprotein; Cholesterol; High-density lipoprotein (HDL); Liver metabolism; Mouse; Transcriptomics
Settore BIOS-11/A - Farmacologia
Settore BIOS-12/A - Anatomia umana
Articolo
Esperti anonimi
Pubblicazione scientifica
   Next generation advanced RNA inhibition therapy to treat cardiometabolic disease (LiverTarget)
   LiverTarget
   EUROPEAN COMMISSION
   101057724

   A sound microbiota in a sound body through apolipoprotein A-I and HDL: from mouse models to humans (OCTOPUS)
   OCTOPUS
   MINISTERO DELL'ISTRUZIONE E DEL MERITO
ago-2025
18-feb-2025
Elsevier B.V.
35
8
103920
1
12
12
Pubblicato
Periodico con rilevanza internazionale
crossref
Aderisco
info:eu-repo/semantics/article
The lack of apoA-I in apoE-KO mice affects the liver transcriptome / E. Franchi, A. Colombo, S. Manzini, M. Busnelli, G. Chiesa. - In: NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. - ISSN 0939-4753. - 35:8(2025 Aug), pp. 103920.1-103920.12. [10.1016/j.numecd.2025.103920]
open
Prodotti della ricerca::01 - Articolo su periodico
5
262
Article (author)
Periodico con Impact Factor
E. Franchi, A. Colombo, S. Manzini, M. Busnelli, G. Chiesa
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0939475325000742-main.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 11.79 MB
Formato Adobe PDF
11.79 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1174566
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
  • OpenAlex ND
social impact